Table 2.
Seroprevalence of antibodies to Toxoplasma gondii according to pregnancy and age
| Status | Age | Pregnant | Total | ||||
|---|---|---|---|---|---|---|---|
| ≤ 29 (n (%)) | 30–34 (n (%)) | ≥ 35 (n (%)) | No (n = 147) | Yes (n = 55) | P value | ||
| IgG+ | 46(59.7%) [48.6–69.9] | 44(65.7%) [53.7–75.9] | 43(74.1%) [61.6–83.7] | 106(72.1%) [64.4–78.7] | 27(49.1%) [36.4–61.9] | 0.002a | 133(65.8%) [59.1–72.1] |
| IgM+ | 11(14.3%) [8.2–23.8] | 4(5.9%) [2.3–14.4] | 4(6.9%) [2.7–16.4] | 17(11.5%) [7.3–17.7] | 2(3.6%) [1–12.3] | 0.086a | 19(9.4%) [6.1–14.2] |
| IgG+ and IgM+ | 10(12.9%) [7.2–22.3] | 4(5.9%) [2.3–14.4] | 4(6.9%) [2.7–16.4] | 17(11.5%) [7.3–17.7] | 1(1.8%) [0.3–9.6] | 0.028b | 18(8.9%) [5.7–13.6] |
| IgG+ or IgM+ | 47(61.04%) [49.9–71.7] | 44(65.7%) [53.7–75.9] | 43(74.1%) [61.6–83.7] | 106(72.1%) [64.4–78.7] | 28(50.9%) [38.1–63.6] | 0.005a | 134(66.3%) [59.6–72.5] |
| IgG- and IgM- | 30(38.9%) [29.8–50.1] | 23(34.3%) [24.1–46.3] | 15(25.9%) [16.3–38.4] | 41(27.9%) [21.3–35.6] | 27(49.1%) [36.4–61.9] | 0.005a | 68(33.7%) [27.5–40.4] |
| IgG- and IgM + | 1(1.3%) [0.2–7] | 0(0%) [0–5.4] | 0(0%) [0–6.2] | 0(0%) [0–2.5] | 1(1.8%) [0.3–9.6] | 0.272b | 1(0.5%) [0.1–2.8] |
Prevalence is presented as number (%) and [CI 95%] that calculated by Newcombe method
aChi2 test
bFisher exact test